About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Therapeutics and Clinical Risk Management
›
Top Articles
Therapeutics and Clinical Risk Management
Pharmacology
,
Chemical Engineering
2.9
(top 6%)
Impact Factor
3.1
(top 6%)
extended IF
60
(top 7%)
H-Index
1.7K
authors
2.2K
papers
29.1K
citations
4.6K
citing journals
22K
citing authors
Most Cited Articles of Therapeutics and Clinical Risk Management
Title
Year
Citations
Factors affecting therapeutic compliance: A review from the patient's perspective
2008
652
The challenge of patient adherence
2005
477
Epidemiology and risk factors for invasive candidiasis
2014
364
New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events
2015
227
Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review
2017
194
The benefits and risks of testosterone replacement therapy: a review
2009
192
Cannabinoids in the management of difficult to treat pain
2008
162
Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)
2007
147
Bortezomib (Velcadetrade mark) in the Treatment of Multiple Myeloma
2006
145
Neural circuits in anxiety and stress disorders: a focused review
2015
141
Lopinavir/ritonavir in the treatment of HIV-1 infection: a review
2008
138
Comparison of echinocandin antifungals
2007
138
Diagnosis and management of xerostomia and hyposalivation
2015
136
The use of calcium and vitamin D in the management of osteoporosis
2008
127
Pharmacological causes of hyperprolactinemia
2007
120
Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management
2007
119
Antibiotic prescribing practices by dentists: a review
2010
113
Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs
2015
99
Recurrent respiratory papillomatosis: current and future perspectives
2015
99
In vitro fertilization (IVF): a review of 3 decades of clinical innovation and technological advancement
2006
96
Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis
2017
95
Advances in diagnosis and treatment of trigeminal neuralgia
2015
93
A review of nasal polyposis
2008
92
Epidemiology of Japanese encephalitis: past, present, and future prospects
2015
91
The therapeutic effects of Rho-ROCK inhibitors on CNS disorders
2008
91
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.